{
    "title": "Costly eye drug and far cheaper alternative have similar side effects -study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-2755784/Costly-eye-drug-far-cheaper-alternative-similar-effects-study.html",
    "date": "2014-09-14",
    "keywords": [
        "lucentis",
        "avastin",
        "cochrane",
        "eye",
        "wamd",
        "roche",
        "drug",
        "side",
        "study",
        "health",
        "novartis",
        "safety",
        "review",
        "gmt",
        "september",
        "cancer",
        "treatment",
        "medicine",
        "france",
        "use",
        "email",
        "ben",
        "hirschlerlondon",
        "row",
        "analysis",
        "evidencethe",
        "monday",
        "journal",
        "collaboration",
        "group",
        "trial",
        "value",
        "drugsthere",
        "debate",
        "cutprice",
        "alternative",
        "degeneration",
        "cause",
        "blindness",
        "elderlyavastin",
        "way",
        "condition",
        "eylea",
        "bayer",
        "regeneron",
        "number",
        "basis",
        "service",
        "issue",
        "europe",
        "july",
        "scrutiny",
        "italy",
        "suspicion",
        "differencein",
        "dose",
        "injection",
        "lucentisnovartis",
        "substitution",
        "purposesa",
        "vision",
        "loss",
        "paper",
        "rate",
        "disordersdavid",
        "tovey",
        "editor",
        "chief",
        "library",
        "question",
        "importance",
        "evidencenovartis",
        "statement",
        "profile",
        "contrast",
        "authoritiesroche",
        "aspectslucentis",
        "companys",
        "seller",
        "year",
        "dollar",
        "euroediting",
        "goodman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}